Szénási P, Tóth L, Romics L, Kammerer L
Semmelweis Orvostudományi Egyetem, III. Belgyógyászati Klinika, Budapest, Hungary.
Acta Diabetol Lat. 1988 Jan-Mar;25(1):7-12. doi: 10.1007/BF02581240.
In vitro platelet aggregometry was performed in 201 patients with diabetes mellitus, and in 106 controls. The complication-free and retinopathic patients showed hyperaggregability to collagen and arachidonic acid, and also to epinephrine and adenosine diphosphate when neuropathy occurred. Patients with nephropathy, both with and without azotemia, had diminished in vitro platelet responses to each of the four stimuli as compared to age- and sex-matched controls. These characteristics were independent of the type of diabetes. It is concluded that diabetic nephropathy is characterized by reduced platelet in vitro reactivity. Further research is necessary to explain in vitro hypoaggregability in contrast to the numerous proofs of in vivo hyperfunction of platelets in diabetes.
